|
|
Volumn 48, Issue 2, 2000, Pages 121-129
|
|
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo
|
|
Author keywords
Apoptosis; Bcl 2; Immunohistochemistry; p53; Proliferation; Transglutaminase
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
KI 67 ANTIGEN;
MONOCLONAL ANTIBODY KI 67;
PROTEIN BCL 2;
PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;
PROTEIN P53;
ADULT;
AGED;
APOPTOSIS;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER RECURRENCE;
CANCER TISSUE;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
DISEASE COURSE;
DNA NICK TRANSLATION;
FEMALE;
GLIOBLASTOMA;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
IN VIVO STUDY;
MALE;
POSTOPERATIVE CARE;
PROTEIN EXPRESSION;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
BIOLOGICAL MARKERS;
BRAIN NEOPLASMS;
CELL DIVISION;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
CRANIAL IRRADIATION;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DISEASE PROGRESSION;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENES;
GENES, BCL-2;
GLIOBLASTOMA;
GTP-BINDING PROTEINS;
HUMANS;
KI-67 ANTIGEN;
LIFE TABLES;
LOMUSTINE;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NIMUSTINE;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RADIOTHERAPY, ADJUVANT;
SURVIVAL ANALYSIS;
TENIPOSIDE;
TRANSGLUTAMINASES;
TUMOR STEM CELLS;
TUMOR SUPPRESSOR PROTEIN P53;
|
|
EID: 0033772462
PISSN: 0167594X
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1006462618800 Document Type: Article |
|
Times cited : (14)
|
|
References (24)
|
